Eradicating the Viral Triad in Hemodialysis Units

Adv Chronic Kidney Dis. 2019 May;26(3):157-161. doi: 10.1053/j.ackd.2019.01.008.

Authors

Beth Adams¹, Jerry Yee²

Affiliations

¹ Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI.
² Henry Ford Hospital, Detroit, MI; Professor of Clinical Medicine, Wayne State University, Detroit, MI.

PMID: 31202386
DOI: 10.1053/j.ackd.2019.01.008

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active
Antiviral Agents / therapeutic use
Comorbidity
Glomerulonephritis / virology
HIV Infections / drug therapy*
HIV Infections / epidemiology
Hemodialysis Units, Hospital
Hepatitis B / epidemiology
Hepatitis B / prevention & control*
Hepatitis B Vaccines / therapeutic use
Hepatitis C / drug therapy*
Hepatitis C / epidemiology
Humans
Kidney Diseases / virology
Kidney Failure, Chronic / epidemiology
Kidney Failure, Chronic / therapy*
Renal Dialysis
Renal Insufficiency, Chronic / epidemiology
Renal Insufficiency, Chronic / therapy*

Substances

Anti-HIV Agents
Antiviral Agents
Hepatitis B Vaccines